Literature DB >> 9869641

Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).

L Hengst1, U Göpfert, H A Lashuel, S I Reed.   

Abstract

Cell-cycle phase transitions are controlled by cyclin-dependent kinases (Cdks). Key to the regulation of these kinase activities are Cdk inhibitors, proteins that are induced in response to various antiproliferative signals but that can also oscillate during cell-cycle progression, leading to Cdk inactivation. A current dogma is that kinase complexes containing the prototype Cdk inhibitor p21 transit between active and inactive states, in that Cdk complexes associated with one p21 molecule remain active until they associate with additional p21 molecules. However, using a number of different techniques including analytical ultracentrifugation of purified p21/cyclin A/Cdk2 complexes we demonstrate unambiguously that a single p21 molecule is sufficient for kinase inhibition and that p21-saturated complexes contain only one stably bound inhibitor molecule. Even phosphorylated forms of p21 remain efficient inhibitors of Cdk activities. Therefore the level of Cdk inactivation by p21 is determined by the fraction of kinase complexed with the inhibitor and not by the stoichiometry of inhibitor bound to the kinase or the phosphorylation state of the Cdk inhibitor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869641      PMCID: PMC317274          DOI: 10.1101/gad.12.24.3882

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  22 in total

Review 1.  The INK4 family of CDK inhibitors.

Authors:  A Carnero; G J Hannon
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

Review 2.  Estimation of molecular size and molecular weights of biological compounds by gel filtration.

Authors:  P Andrews
Journal:  Methods Biochem Anal       Date:  1970

Review 3.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

Review 4.  Principles of CDK regulation.

Authors:  D O Morgan
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

5.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.

Authors:  Y Luo; J Hurwitz; J Massagué
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

7.  A cell cycle-regulated inhibitor of cyclin-dependent kinases.

Authors:  L Hengst; V Dulic; J M Slingerland; E Lees; S I Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Authors:  Y Li; C W Jenkins; M A Nichols; Y Xiong
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

9.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

10.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

View more
  36 in total

1.  HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression.

Authors:  P Castella; S Sawai; K Nakao; J A Wagner; M Caudy
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle.

Authors:  Jia-Yun Chen; Jia-Ren Lin; Feng-Chiao Tsai; Tobias Meyer
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

3.  Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.

Authors:  Bipin C Dash; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  An integrated view of cyclin E function and regulation.

Authors:  Ka Tat Siu; Marsha Rich Rosner; Alex C Minella
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

5.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis.

Authors:  Manjula Karpurapu; Dong Wang; Nikhlesh K Singh; Quanyi Li; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

7.  Genetic evidence for functional dependency of p18Ink4c on Cdk4.

Authors:  Xin-Hai Pei; Feng Bai; Tateki Tsutsui; Hiroaki Kiyokawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.

Authors:  Hung-Chuan Chiu; Wei-Ru Huang; Tsai-Ling Liao; Pei-I Chi; Brent L Nielsen; Jyung-Hurng Liu; Hung-Jen Liu
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

9.  p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.

Authors:  Magdalena B Flak; Claire M Connell; Claude Chelala; Kyra Archibald; Michael A Salako; Katrina J Pirlo; Michelle Lockley; Sally P Wheatley; Frances R Balkwill; Iain A McNeish
Journal:  Mol Cancer       Date:  2010-07-03       Impact factor: 27.401

10.  Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma.

Authors:  Ellen Hukkelhoven; Yuhui Liu; Nancy Yeh; Daniel Ciznadija; Stacy W Blain; Andrew Koff
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.